Last reviewed · How we verify

NCT04315805

Integrative Yoga Therapy for Patients With Chronic Pain and Psychological Distress

Status unknown NA Last updated 20 March 2020
What this trial tests

NA trial testing Integrative Yoga Therapy in Chronic Pain in 72 participants. Status unknown.

Timeline
15 June 2020
Primary endpoint
15 November 2020
15 December 2020

Quick facts

Lead sponsorAarogyam UK
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposesupportive care
Enrollment72
Start date15 June 2020
Primary completion15 November 2020
Estimated completion15 December 2020
Sites1 location across United Kingdom

Drugs / interventions tested

Conditions studied

Sponsor

Aarogyam UK — full company profile →

Who can join

Adults 18 to 65, any sex, with Chronic Pain or Psychological Distress. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study will be a randomized wait list controlled trial studying the efficacy of an Integrative Yoga Therapy for patients with chronic pain and psychological distress. Individualised yoga program will consist of a 8-week guided self-help program. This study will primarily investigate whether an individually tailored yoga can be beneficial for patients suffering from chronic pain reducing pain, anxiety depression, while improving overall quality of life.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Integrative Yoga Therapy

Trials testing the same drug.

Other recruiting trials for Chronic Pain

Currently open trials in the same condition.

Other Aarogyam UK trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04315805.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing